8,16,24,32-Tetraoxa-2,10,18,26,34-pentaazanonatriacontanoic acid,39-hydroxy-9,17,25,33-tetraoxo-, methyl ester (5709-84-2)

Other Product

• 1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
• 1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
• 1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
• 1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
• 1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
• 1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
• 1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
• Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
• Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
• 1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
• (2R,3R)-N-{(1'S,2S,7'R,9'Z,17'S,20'S,21'S,29'S,32'R)-29'-benzyl-32'-[(1R)-1-hydroxyethyl]-7',20',28'-trimethyl-24'-[(1S)-1-methylpropyl]-11',14',18',22',25',27',30',33'-octaoxospiro[oxirane-2,8'-[6,15,19]trioxa[12,23,26,28,31,34]hexaazatricyclo[15.9.8.2~2
• 6,11,24,29-Tetraoxa-2,15,20,33,38-pentaazatetracontanedioic acid,39-[[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]methyl]-16,19,34,37-tetraoxo-, 1-(1,1-dimethylethyl) ester, (S)-
• 1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
• 7,10,17,20-Tetraoxahexacosanedioic acid,8-[[(2-ethyl-1-oxohexyl)oxy]methyl]-18-methyl-6,11,16,21-tetraoxo-,26-(3-methoxybutyl) 1-octyl ester
• 1/C23H22N2O2/c26-23(27-22-15-25-11-7-17(22)8-12-25)21-14-18(13-16-5-9-24-10-6-16)19-3-1-2-4-20(19)21/h1-6,9-10,13-14,17,22H,7-8,11-12,15H2/b18-13
• Colony-stimulatingfactor 2 (human clone pHG25 protein moiety reduced), 23-L-leucine-27-L-asparticacid-39-L-glutamic acid-, (127®9')-protein with 9-glycine-10-glycine-11-glycine-12-glycine-13-L-serine-14-glycine-15-glycine-16-glycine-18-glycine-19-L-serine-34-L-asparticacid-89-L-aspartic acid-9-152-interleukin 3 (human clone D11 precursor proteinmoiety reduced)
• Neuropeptide Y (human),24-L-leucinamide-25-de-L-arginine-26-de-L-histidine-27-de-L-tyrosine-28-de-L-isoleucine-29-de-L-asparagine-30-de-L-leucine-31-de-L-isoleucine-32-de-L-threonine-33-de-L-arginine-34-de-L-glutamine-35-de-L-arginine-36-de-L-tyrosinamide-(9CI)
• 11',29'-di-tert-butyl-5',17',23',35',38',40',43',45'-octamethyl-7',15',25',33'-tetraoxadispiro[cyclohexane-1,2'-heptacyclo[32.2.2.2~3,6~.2~16,19~.2~21,24~.1~9,13~.1~27,31~]hexatetracontane-20',1''-cyclohexane]-1'(36'),3',5',9'(44'),10',12',16',18',21',23'
• 1/C19H20O5/c1-11(2)7-18(21)24-19(3,4)16-9-13-8-12-5-6-17(20)23-14(12)10-15(13)22-16/h5-8,10,16H,9H2,1-4H
• 1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H